Company Overview and News

Citic Telecom: Cheap Combination Of High Yield And Steady Growth

2018-02-28 seekingalpha
Citic Telecom is the cheapest among its listed peers on both P/E and EV/EBITDA and also offers the highest dividend yield at close to 6%.

RCom’s lost decade of aborted asset sales grinds on

2017-10-04 livemint
Mumbai: Billionaire Anil Ambani’s battle to chip away at the Rs457 billion ($7 billion) his telecom company owes its debtors seems to get harder with each passing day.

Anil Ambani's Lost Decade of Aborted Phone-Tower Sales Grinds On - Bloomberg

2017-10-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Hutchison Telecom shares soar on speculation over bidding for its fixed-line network business

2017-07-19 scmp
Private equity companies TPG Capital and MBK Partners look to be front-runners for Hutchison Global Communications

Citic Telecom in quest for more strategic acquisitions

2017-03-20 scmp
Citic Telecom International Holdings, a subsidiary of China’s largest conglomerate, plans to pursue more strategic acquisitions and alliances after reporting a moderate rise in profit last year.

CITIC Telecom CPC Receives 2016 Frost & Sullivan Taiwan Cloud Service Provider of the Year Award

2016-09-27 prnewswire
TAIPEI, Taiwan, Sept. 27, 2016 /PRNewswire/ -- CITIC Telecom International CPC Limited (CITIC Telecom CPC), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883), today announced it has been honored as a best-in-class cloud service provider in delivering high performance and reliable cloud computing services. By receiving the 2016 Frost & Sullivan Taiwan Cloud Service Provider of the Year, CITIC Telecom CPC was recognized for its innovative use of the latest technology and high quality services in order to help enterprises protect their businesses through its SmartCLOUD™ cloud computing solutions.

Citic Telecom sets sights on global expansion after mixed first-half earnings

2016-08-16 scmp
Citic Telecom International Holdings, a subsidiary of China’s largest conglomerate, plans to accelerate its international expansion after posting uneven financial results in the first six months of this year.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

13h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

13h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...